ResMed Aktie
WKN DE: 895878 / ISIN: US7611521078
|
28.09.2017 22:05:00
|
ResMed to Announce First Quarter Fiscal Year 2018 Results
SAN DIEGO, Sept. 28, 2017 /PRNewswire/ -- ResMed (NYSE: RMD) today announced it will report its first quarter of fiscal year 2018 results on Thursday, October 26, 2017, after the New York Stock Exchange market closes. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.
The earnings webcast is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed's Investor Relations website at investor.resmed.com. Please go to this section of the website and click on the icon for the "Q1 2018 earnings webcast."
Please note that we do not use outside phone lines to access the earnings call.
International earnings webcast times will be:
Thursday, October 26, 9:30 p.m. | London |
Friday, October 27, 7:30 a.m. | Sydney |
A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from October 26, 2017, until November 9, 2017, at:
US: | +1 800-585-8367 |
Outside US: | +1 416-621-4642 |
Passcode: | 93203758 |
About ResMed
ResMed (NYSE: RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 3 million patients remotely monitored every day. Our 6,000-strong team is committed to creating the world's best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 120 countries. ResMed.com | Facebook | Twitter | LinkedIn.
For media | For investors |
Alison Graves | Agnes Lee |
+1 858-836-6789 | +1 858-836-5971 |
View original content with multimedia:http://www.prnewswire.com/news-releases/resmed-to-announce-first-quarter-fiscal-year-2018-results-300527872.html
SOURCE ResMed Inc.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ResMed Inc.mehr Nachrichten
|
25.04.25 |
S&P 500-Papier ResMed-Aktie: So viel Gewinn hätte ein Investment in ResMed von vor einem Jahr eingefahren (finanzen.at) | |
|
24.04.25 |
S&P 500 aktuell: S&P 500 letztendlich mit positivem Vorzeichen (finanzen.at) | |
|
24.04.25 |
Handel in New York: S&P 500 notiert am Nachmittag im Plus (finanzen.at) | |
|
24.04.25 |
NYSE-Handel: So entwickelt sich der S&P 500 am Donnerstagmittag (finanzen.at) | |
|
24.04.25 |
Optimismus in New York: S&P 500 startet in der Gewinnzone (finanzen.at) | |
|
22.04.25 |
Ausblick: ResMed informiert über die jüngsten Quartalsergebnisse (finanzen.net) | |
|
18.04.25 |
S&P 500-Papier ResMed-Aktie: So viel Gewinn hätte ein Investment in ResMed von vor 10 Jahren abgeworfen (finanzen.at) | |
|
11.04.25 |
S&P 500-Titel ResMed-Aktie: So viel Gewinn hätte ein Investment in ResMed von vor 5 Jahren eingebracht (finanzen.at) |
Analysen zu ResMed Inc.mehr Analysen
Aktien in diesem Artikel
| ResMed Inc. | 201,50 | 0,80% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.